The pharmaceutical industry has a long history with Bayesian statistics. Already in 1986, Racine, Grieve, Flühler and Smith wrote an article entitled Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry[1], highlighting four typical applications they encountered at that time. Since then, Bayesian methods have been applied to many more problems in the pharmaceutical...
The Bayesian approach in general has a lot to offer in times of Machine Learning (ML) and Artificial Intelligence (AI). The Bayesian framework itself offers a learning environment, where the prior, and, subsequently the posterior distributions can be updated sequentially, and where human expertise can be incorporated. The approach allows for uncertainty quantification of all quantities of...
Lessons learned in the last 25 years
Gerhard Nehmiz, consultant for Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
gerhard.nehmiz.ext@boehringer-ingelheim.com
The Working Group "Bayes methods" of the IBS / German Region was founded in 2001, and met a need. It had two roots: The WG "Prognosis and decision making" of the GMDS (U. Mansmann) and the German BUGS User Group...
